Safety and Effectiveness of Fast-Track Systems in Pediatric Urgent Care Units: A Systematic Review

Mohammad Alahmadi1

  • 1Pediatrics, King Abdulaziz University, Jeddah, SAU.

Cureus
|April 27, 2026
PubMed

Insights

Fast-track systems in pediatric emergency care improve operational efficiency, reducing wait times and length of stay. These systems demonstrate stable safety outcomes, enhancing patient flow and caregiver satisfaction.

Area of Science:

  • Pediatric Emergency Medicine
  • Healthcare Operations Research
  • Systematic Review and Meta-Analysis

Background:

  • Emergency department overcrowding and long wait times are significant issues in pediatric care.
  • Fast-track systems aim to improve patient flow and reduce delays in pediatric urgent care settings.

Purpose of the Study:

  • To systematically review the effectiveness and safety of fast-track systems in pediatric emergency and urgent care.
  • To evaluate the impact of fast-track implementation on operational efficiency and patient outcomes.

Main Methods:

  • Systematic literature search of major databases (PubMed/MEDLINE, Embase, CINAHL, Cochrane) from 2014-2024.
  • Screening and selection of studies adhering to PRISMA 2020 guidelines.
  • Inclusion of 14 studies, primarily quality improvement and retrospective cohort designs, from North America, Europe, Asia, and Australia.

Main Results:

  • Fast-track systems were associated with improved operational efficiency, including reduced length of stay (8.9%-36%) and waiting times.
  • Improvements in patient flow metrics such as decreased left-without-being-seen rates and short-stay admissions were observed.
  • Safety outcomes, including 72-hour return visits and 30-day readmissions, showed no statistically significant increase; caregiver satisfaction improved in four studies.

Conclusions:

  • Fast-track systems in pediatric emergency settings enhance operational performance, reducing length of stay and wait times while maintaining safety.
  • Successful implementation depends on factors like dedicated space, staffing, and standardized protocols.
  • Further research is needed on long-term safety, sustainability, and applicability in diverse settings.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
401
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
548
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
955
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K